Connect with us


Open Book Extracts joins EIHA to gain novel food status in Europe



Open Book Extracts will work with other companies to help provide safe cannabis products throughout Europe

US-based Open Book Extracts is in the process of achieving compliance with novel food regulations as it prepares to make its move on the European market.

The major cannabinoid manufacturer has announced it has joined the European Industrial Hemp Association’s (EIHA) Novel Food Consortium in order to gain novel food approval regarding the distribution of CBD ingredients.

The EIHA Novel Food Consortium, officially launched in June 2020, is the Association’s project aimed at clearing the way for hemp foods and extracts – including CBD – in the UK and European Union member states.

By joining the Consortium established by the EIHA, Open Book Extracts is joining forces with other companies to pursue the safety studies to provide safe and ready access to cannabinoid-based products throughout the UK and EU.

“We are witnessing a pivotal moment in history when the global appetite for access to cannabinoids is very high,” said CEO, Dave Neundorfer.

“We see this in the US with many recent positive discussions among US congressional officials to pass legislation for federal legalisation of cannabis but also new bills for CBD to be regulated as a dietary supplement.”

“We appreciate the EIHA and its members working together to respond to a common challenge by investing in unprecedented studies, and look forward to the EU quickly solidifying their plans to implement a parallel framework where these same studies can be applied. We are also pleased to offer our clients the ability to sublicense our membership in the Novel Foods Consortium to bring their premium CBD products to market in the UK and eventually the EU.”

Powered by their cGMP operations in North Carolina and a team of world-class scientists, Open Book Extracts offers one of the largest portfolios of cannabinoid isolates at purity, including CBD, CBG, CBN, CBC, and THCV, all at greater than 99 percent purity.

It also produces formulation services and turnkey finished good manufacturing including edibles, softgels, tablets, tinctures, and a full range of topical products.

Neundorfer continued: “As Open Book Extracts proceeds down the path to achieve compliance with world-wide regulations, we are positioned to become the leading global supplier of cannabinoids while continuing to maintain 100 percent dedication to premium quality, science-driven consistency, sustainability, transparency, and positive, trustworthy relationships with our clients and community.”

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.